Doctors Note Logo

Published on: 9/28/2026

Gemtesa Side Effects: What to Expect for Overactive Bladder

Gemtesa (vibegron) treats overactive bladder by relaxing the bladder muscle, and most side effects are mild, including headache, cold-like symptoms, diarrhea, nausea, and urinary tract infection. Less common but more serious risks include urinary retention, which is more likely in people with bladder outlet obstruction or those also taking anticholinergic medications, along with rare allergic reactions such as swelling of the face, lips, or throat. Timing matters too, since some effects fade within the first few weeks while others signal a need to stop the drug, and several factors influence your personal risk. See below to understand more about which symptoms warrant a call to your doctor and which ones typically resolve on their own.

If you are unsure whether what you are feeling is a normal adjustment to Gemtesa or something that needs prompt attention, a free, instant, online symptom check can help you organize your symptoms, weigh possible causes, and understand which next steps make sense before your next appointment.

Last reviewed for medical accuracy: 09/28/2026

answer background

Explanation

Gemtesa Side Effects: What to Expect for Overactive Bladder

Gemtesa (vibegron) is a prescription medication approved to treat overactive bladder (OAB) symptoms—urgency, frequency, and urge urinary incontinence. Like any drug, Gemtesa can cause side effects. This guide reviews what to expect, how to manage common reactions, and when to speak to your doctor about serious concerns.


How Gemtesa Works

Gemtesa belongs to a class called β3-adrenergic agonists. It relaxes the bladder muscle (detrusor) during the storage phase, increasing bladder capacity and reducing the sudden urges to urinate that disrupt daily life and sleep.


Common Gemtesa Side Effects

Most side effects are mild to moderate and improve over time. In clinical trials, these were the most frequently reported:

  • Headache (≈7–8%)
    • Often mild; resolves within a few hours
    • Manage with over-the-counter pain relievers (acetaminophen or ibuprofen) unless contraindicated
  • Urinary Tract Infection (UTI) (≈5–6%)
    • Signs: burning with urination, cloudy or strong-smelling urine, pelvic discomfort
    • Keep well hydrated; report symptoms early to prevent complications
  • Nasopharyngitis (common cold) (≈3–4%)
    • Runny or stuffy nose, sore throat
    • Rest, fluids, and over-the-counter remedies usually help
  • Diarrhea (≈2–3%)
    • Stay hydrated; use bland foods (bananas, rice, toast) until it clears
  • Constipation (≈2%)
    • Increase fiber (fruits, vegetables, whole grains) and water intake
    • Gentle exercise can stimulate bowel movements
  • Nausea (≈2%)
    • Take Gemtesa with food to lessen stomach upset
  • Back Pain
    • Usually mild; treat as you would other muscle aches

These side effects often appear within the first few weeks and improve as your body adjusts.


Less Common But Important Reactions

While rarer, these warrant attention and may require dose adjustment or treatment discontinuation.

  • Increased Blood Pressure
    • Monitor your blood pressure regularly, especially if you have hypertension
    • Notify your doctor if readings rise above your usual range
  • Headache That Persists or Worsens
    • Severe headaches not relieved by usual measures
    • May indicate a need to reassess therapy
  • Severe Constipation
    • No bowel movement for several days, accompanied by pain or vomiting
    • Seek medical advice; may require laxatives or further evaluation
  • Urinary Retention
    • Inability to pass urine, lower abdominal swelling
    • This is rare but potentially serious—contact a healthcare provider immediately
  • Allergic Reactions
    • Symptoms: rash, itching, swelling of face/lips/tongue, difficulty breathing
    • Stop Gemtesa and seek emergency care if breathing or swallowing is affected

Managing Side Effects: Practical Tips

  1. Stay Hydrated
    • Aim for 6–8 cups of water daily unless restricted by your doctor
  2. Eat Balanced, High-Fiber Meals
    • Helps prevent constipation—include whole grains, fruits, vegetables
  3. Track Your Symptoms
    • Keep a bladder diary: record times of urination, leaks, fluid intake, and side effects
    • Brings clear data to follow-up visits
  4. Take with Food
    • Reduces nausea and stomach upset
  5. Over-the-Counter Aids
    • For occasional headaches: acetaminophen or ibuprofen
    • For constipation: bulk-forming fiber supplements (e.g., psyllium)
  6. Lifestyle Adjustments
    • Pelvic floor exercises (“Kegels”) can improve bladder control
    • Avoid bladder irritants: caffeine, alcohol, and acidic foods

When to Seek Medical Help

Gemtesa is generally well tolerated, but certain warning signs mean you should contact your healthcare provider right away:

  • Sudden inability to urinate or severe lower abdominal pain
  • Persistent high blood pressure readings
  • Signs of a severe allergic reaction (swelling of face/throat, difficulty breathing)
  • Unrelenting headache not helped by usual remedies
  • Persistent vomiting or severe diarrhea leading to dehydration

If you experience any life-threatening or serious symptoms, seek emergency care or call your doctor immediately.


Special Considerations

  • Kidney or Liver Issues
    • Gemtesa does not require dose adjustment in mild to moderate impairment, but follow your doctor’s guidance
  • Drug Interactions
    • Tell your doctor about all prescription and over-the-counter medications, vitamins, or supplements you take
    • Gemtesa has a low risk of major interactions but always check before adding new treatments
  • Pregnancy and Breastfeeding
    • Limited data exist. Discuss risks and benefits with your healthcare professional if you are pregnant or nursing
  • Missed Dose
    • If you miss a dose, take it as soon as you remember on the same day. Do not double up the next day.

Use an Online Symptom Checker

Wondering whether your symptoms are related to Gemtesa or something else? Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you sort symptoms and decide if you need to contact your provider.

free, online symptom check, using the doctor approved Ubie Symptom Checker


Talking with Your Doctor

Always discuss any new or worsening symptoms with your healthcare provider. They can:

  • Confirm whether your side effects are likely from Gemtesa
  • Adjust your dose or suggest alternative therapies
  • Order tests (e.g., blood pressure monitoring, kidney/liver function)
  • Provide referrals to specialists if needed

Keep a list of questions and bring your bladder diary to appointments. Open communication ensures you receive the safest, most effective care.


Bottom Line

Gemtesa offers a non-anticholinergic option for managing overactive bladder, with most side effects being mild and manageable. By staying informed, tracking your experience, and seeking prompt medical advice when necessary, you can maximize benefits and minimize discomfort.

Speak to a doctor about any side effects that concern you—especially those that could be serious or life threatening. Your healthcare team is your best resource for personalized guidance.

(References)

  • * Frankel J, Varano S, Staskin D, Shortino D, Jankowich R, Mudd PN Jr. Vibegron improves quality-of-life measures in patients with overactive bladder: Patient-reported outcomes from the EMPOWUR study. Int J Clin Pract. 2021 May;75(5):e13937. doi: 10.1111/ijcp.13937. Epub 2021 Jan 22. PMID: 33332699; PMCID: PMC8244055.

  • * He W, Huang G, Cui W, Tian Y, Sun Q, Zhao X, Zhao Y, Li D, Liu X. Comparative assessment of efficacy and safety of approved oral therapies for overactive bladder: a systematic review and network meta-analysis. Int Braz J Urol. 2023 Sep-Oct;49(5):535-563. doi: 10.1590/S1677-5538.IBJU.2023.0158. PMID: 37506033; PMCID: PMC10482468.

  • * Yamamoto S, Kusabuka H, Matsuzawa A, Maruyama I, Yamazaki T. Vibegron shows high selectivity and potent agonist activity for β3-adrenoceptors, irrespective of receptor density. PLoS One. 2023;18(9):e0290685. doi: 10.1371/journal.pone.0290685. Epub 2023 Sep 1. PMID: 37656760; PMCID: PMC10473532.

  • * Chastek B, Carrera A, Landis C, Snyder D, Abedinzadeh L, Bancroft T, Nesheim J, Kennelly M, Staskin D. Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis. Adv Ther. 2024 May;41(5):2086-2097. doi: 10.1007/s12325-024-02824-x. Epub 2024 Mar 23. PMID: 38520502; PMCID: PMC11052770.

  • * Yoshimura S, Yagi H, Abe K, Yamasaki M. Safety and Effectiveness of Vibegron in Japanese Patients With Overactive Bladder: A Japanese Postmarketing Survey. Low Urin Tract Symptoms. 2024 Nov;16(6):e12535. doi: 10.1111/luts.12535. PMID: 39497630; PMCID: PMC11588590.

  • * Woo J, Washington C, Aikin D, Colamarino RB, Worz C, Abedinzadeh L. Suitability of Crushed Vibegron 75 mg Tablets for Enteral Administration. Sr Care Pharm. 2025 Apr 1;40(4):185-193. doi: 10.4140/TCP.n.2025.185. PMID: 40134043.

  • * Huang W, Zheng X, Luo J, Chen Y, Xu Y. Comparative efficacy and adverse effects of β3-agonists and antimuscarinics in overactive bladder: a network and component network meta-analysis. Eur J Clin Pharmacol. 2025 Aug;81(8):1217-1227. doi: 10.1007/s00228-025-03855-1. Epub 2025 Jun 7. PMID: 40483336.

  • * Peters KM, Owens-Grillo J, Thomas E, Staskin D, Rovner ES, Mujais S. Clinically Meaningful Improvements With Vibegron in Men With Overactive Bladder and Benign Prostatic Hyperplasia: A Responder Analysis of the Phase 3 COURAGE Trial. Urology. 2025 Dec;206:150-156. doi: 10.1016/j.urology.2025.08.051. Epub 2025 Sep 1. PMID: 40902908.

  • * He W, Wang C, Chen B, Li M, Zhang X, Cui W, Sun Q, Jiang X, Liu X. Comparative assessment of oral medications for overactive bladder in older adults: a systematic review and network meta-analysis. Aging Male. 2025 Dec 11;28(1):2568729. doi: 10.1080/13685538.2025.2568729. Epub 2025 Oct 29. PMID: 41159930.

  • * Yamamoto T, Yoshida S, Yajima S, Fukushima H, Yasuda Y, Waseda Y, Sato H, Hirakawa A, Honda H, Komai Y, Matsuo T, Wada N, Masuda H, Fujii Y. Efficacy of Vibegron in Overactive Bladder: A Bayesian Cross-Trial Synthesis of Benefit Probabilities and Decision Thresholds. Low Urin Tract Symptoms. 2026 Sep;18(5):e70095. doi: 10.1111/luts.70095. PMID: 42665534; PMCID: PMC13524839.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.